Displaying items 61-62 of 62 in total
Facing market pressure, Mobileye plans a major CES 2026 reveal of its 'physical AI' and new chip architecture alongside key partner Volkswagen.
IO Biotech’s cancer vaccine posts impressive 5-year survival data, but a narrow miss in its pivotal trial creates an uncertain path in a competitive market.
Get your daily brief delivered to your inbox every morning at 7am
